1. MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasms
- Author
-
C A Hanson, Domenica Caramazza, Sergio Siragusa, Terra L. Lasho, Naseema Gangat, Animesh Pardanani, Christy Finke, A Tefferi, Mrinal M. Patnaik, Patnaik, MM, Lasho, TL, Finke, CM, Gangat, N, Caramazza, D, Siragusa, S, Hanson, CA, Pardanani, A, and Tefferi, A
- Subjects
Male ,Cancer Research ,medicine.medical_specialty ,Genotype ,jak2, mpl mutation, myeloprolifertaive neoplasm ,Polymerase Chain Reaction ,Polymorphism, Single Nucleotide ,Settore MED/15 - Malattie Del Sangue ,Myeloproliferative Disorders ,Polymorphism (computer science) ,hemic and lymphatic diseases ,Internal medicine ,medicine ,Humans ,Genetics ,Thrombopoietin receptor ,Hematology ,Janus kinase 2 ,biology ,Haplotype ,food and beverages ,Janus Kinase 2 ,Middle Aged ,Oncology ,Haplotypes ,Mutation (genetic algorithm) ,Mutation ,Cancer research ,biology.protein ,Female ,Receptors, Thrombopoietin ,hormones, hormone substitutes, and hormone antagonists - Abstract
MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2 V617F-negative myeloproliferative neoplasms
- Published
- 2010